Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramón Barceló

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|January 21, 2006
Malignant mesotheliomaAlberto Muñoz, Ramón Barceló, Guillermo López-Vivanco
Cancer|July 12, 2005
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabineRamón Barceló, Alberto Muñoz, Guillermo López-Vivanco
The New England Journal of Medicine|December 6, 2003
Chemotherapy for bladder cancerAlberto Muñoz, José Ramón Barceló, Guillermo López-Vivanco
Cancer|July 27, 2004
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary siteAlberto Muñoz, José Ramón Barceló, Guillermo López-Vivanco
Archivos Espanoles De Urologia|May 10, 2019
Multiparametric magnetic resonance imaging in prostate cancer detectionEduardo García-Cruz, Catalina Ramón-Barceló, Ramón Carrión-Puig, et al.
Archives of Dermatology|October 19, 2005
Extravasation of docetaxel: a red hand syndromeRamón Barceló, Ainhoa Viteri, Alberto Muñoz, et al.
Medicina Clinica|March 12, 2004
[Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy]Alberto Muñoz, Natalia Fuente, Ramón Barceló, et al.
The Breast Journal|June 17, 2022
Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast CancerIrene Romayor, Marina Luque García-Vaquero, Joana Márquez, et al.
Journal of the American Academy of Dermatology|January 24, 2006
Paclitaxel for progressive basal cell carcinomaRamón Barceló, Ainhoa Viteri, Alberto Muñoz, et al.
Journal of the National Cancer Institute|August 21, 2003
Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancerAlberto Muñoz, Ramón Barceló, Itziar Rubio, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|January 21, 2006
Malignant mesotheliomaAlberto Muñoz, Ramón Barceló, Guillermo López-Vivanco
Cancer|July 12, 2005
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabineRamón Barceló, Alberto Muñoz, Guillermo López-Vivanco
The New England Journal of Medicine|December 6, 2003
Chemotherapy for bladder cancerAlberto Muñoz, José Ramón Barceló, Guillermo López-Vivanco
Cancer|July 27, 2004
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary siteAlberto Muñoz, José Ramón Barceló, Guillermo López-Vivanco
Archivos Espanoles De Urologia|May 10, 2019
Multiparametric magnetic resonance imaging in prostate cancer detectionEduardo García-Cruz, Catalina Ramón-Barceló, Ramón Carrión-Puig, et al.
Archives of Dermatology|October 19, 2005
Extravasation of docetaxel: a red hand syndromeRamón Barceló, Ainhoa Viteri, Alberto Muñoz, et al.
Medicina Clinica|March 12, 2004
[Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy]Alberto Muñoz, Natalia Fuente, Ramón Barceló, et al.
The Breast Journal|June 17, 2022
Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast CancerIrene Romayor, Marina Luque García-Vaquero, Joana Márquez, et al.
Journal of the American Academy of Dermatology|January 24, 2006
Paclitaxel for progressive basal cell carcinomaRamón Barceló, Ainhoa Viteri, Alberto Muñoz, et al.
Journal of the National Cancer Institute|August 21, 2003
Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancerAlberto Muñoz, Ramón Barceló, Itziar Rubio, et al.
Pageof 3